Abstract
An environmentally rapid and benign protocol for the synthesis of 4-aryl-1,4-dihydropyridines compounds using VB1 as a catalyst under microwave irradiation and solvent-free conditions has been achieved. The procedure is operationally simple, giving good to high product yield.
Keywords: 4-Aryl-1, 4-dihydropyridines, VB1, antitumor, antimutagenic, geroprotective, antidiabetic agents, bioactivity, antiaggregatory, aromatic aldehydes
Letters in Organic Chemistry
Title: An Efficient Synthesis of 4-Aryl-1,4-dihydropyridines Via VB1 Catalyzed Hantzsch Reaction
Volume: 8 Issue: 10
Author(s): Chuangang Fan and Mingzhi Song
Affiliation:
Keywords: 4-Aryl-1, 4-dihydropyridines, VB1, antitumor, antimutagenic, geroprotective, antidiabetic agents, bioactivity, antiaggregatory, aromatic aldehydes
Abstract: An environmentally rapid and benign protocol for the synthesis of 4-aryl-1,4-dihydropyridines compounds using VB1 as a catalyst under microwave irradiation and solvent-free conditions has been achieved. The procedure is operationally simple, giving good to high product yield.
Export Options
About this article
Cite this article as:
Fan Chuangang and Song Mingzhi, An Efficient Synthesis of 4-Aryl-1,4-dihydropyridines Via VB1 Catalyzed Hantzsch Reaction, Letters in Organic Chemistry 2011; 8 (10) . https://dx.doi.org/10.2174/157017811799304133
DOI https://dx.doi.org/10.2174/157017811799304133 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Spinal Cord Ischemia/Injury
Current Pharmaceutical Design Patent Selections
Recent Patents on Regenerative Medicine Gene Therapy for Osteoinduction
Current Gene Therapy Perioperative Considerations in Diabetic Patients
Current Diabetes Reviews Malignancy and Radiation-Induced Cardiotoxicity
Cardiovascular & Hematological Disorders-Drug Targets Editorial [ Medicines Da Vinci Code: Deciphering the Intricate Origins of Clinical Neurovascular Pathology K. Maiese ]
Current Neurovascular Research Strategies for Enhancing Progenitor Cell Mobilization and Function in Diabetes
Current Vascular Pharmacology Epigenetic Modifications in Acute Lymphoblastic Leukemia: From Cellular Mechanisms to Therapeutics
Current Gene Therapy CD147: A Novel Modulator of Inflammatory and Immune Disorders
Current Medicinal Chemistry Targeting the Human Thioredoxin System by Diverse Strategies to Treat Cancer and Other Pathologies
Recent Patents on DNA & Gene Sequences The Role of 18 kDa Mitochondrial Translocator Protein (TSPO) in Programmed Cell Death, and Effects of Steroids on TSPO Expression
Current Molecular Medicine CDKN2B-AS1: An Indispensable Long Non-coding RNA in Multiple Diseases
Current Pharmaceutical Design Late Life Depression: A Diagnostic and Pharmacological Review
Current Psychopharmacology Antiplatelet Potential of Plant-Derived Glycosides as Possible Lead Compounds
Current Drug Metabolism Flow Shear Induced Changes in Membrane Fluidity: Dependence on Cell- Substrate Adhesion Strength
Current Analytical Chemistry Left Ventricular Hypertrophy in ADPKD: Changing Demographics
Current Hypertension Reviews Novel Antidepressant Drugs, Arterial Hypertension and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery An Insight into the Recent Diabetes Trials: What is the Best Approach to Prevent Macrovascular and Microvascular Complications?
Current Diabetes Reviews Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter
Current Pharmaceutical Design Isolation and Proteomic Characterization of Bacterial Extracellular Membrane Vesicles
Current Protein & Peptide Science